Prolonged administration of melatonin (1.03 mg intake per mouse per day) in Mdr2 -/- mice improves liver histology and restores the circadian rhythm by interaction with Melatonin receptor 1 (MT1) through decreased angiogenesis and increased glutathione-S transferase activity. Manipulation of clock genes/miR200b pathway by melatonin treatment may be a therapeutic option for primary sclerosing cholangitis patients.

Prolonged Administration of Melatonin Ameliorates Liver Phenotypes in Cholestatic Murine Model

Carpino G;Franchitto A;
2022-01-01

Abstract

Prolonged administration of melatonin (1.03 mg intake per mouse per day) in Mdr2 -/- mice improves liver histology and restores the circadian rhythm by interaction with Melatonin receptor 1 (MT1) through decreased angiogenesis and increased glutathione-S transferase activity. Manipulation of clock genes/miR200b pathway by melatonin treatment may be a therapeutic option for primary sclerosing cholangitis patients.
2022
Cholangiopathies
File in questo prodotto:
File Dimensione Formato  
PIIS2352345X22001655.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 14.76 MB
Formato Adobe PDF
14.76 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14244/4469
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
social impact